318 related articles for article (PubMed ID: 4186583)
1. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
Berceanu S; Gociu M
Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
[No Abstract] [Full Text] [Related]
2. [Immunological behavior of patients with malignant blood diseases].
Luca N
Stud Cercet Med Interna; 1973; 14(5):429-46. PubMed ID: 4202394
[No Abstract] [Full Text] [Related]
3. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
Ponzone A; Tarocco RP; Nicola P
Minerva Pediatr; 1970 Dec; 22(51):2542-60. PubMed ID: 4993895
[No Abstract] [Full Text] [Related]
4. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
Mantovani G; Petrini MT; Tognella S; Grifoni V
Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
[No Abstract] [Full Text] [Related]
5. [Immunological aspects of malignant lymphoproliferative diseases].
Rivero I; Diumenjo M
Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
[No Abstract] [Full Text] [Related]
6. The investigation of the immunological reactivity of patients with haemoblastosis.
Libánský J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 84(2):172-89. PubMed ID: 4161254
[No Abstract] [Full Text] [Related]
7. [Immunopathology in lymphatic systemic diseases].
Huber H; Huber C; Michlmayr G
Verh Dtsch Ges Inn Med; 1973; 79():159-67. PubMed ID: 4133402
[No Abstract] [Full Text] [Related]
8. [Immunologic deficiencies in malignant diseases of the lymphoma group and in multiple myeloma].
Hartl W; Hayduk K
Arch Klin Med; 1967 Nov; 214(1):54-69. PubMed ID: 4872039
[No Abstract] [Full Text] [Related]
9. HL-A antigens and hematologic malignancy.
Miller WV
Arch Intern Med; 1974 Mar; 133(3):397-9. PubMed ID: 4521322
[No Abstract] [Full Text] [Related]
10. [T-and B-lymphocytes in lymphoproliferative syndromes].
Girard JP; Fernandes B
Schweiz Med Wochenschr; 1975 Sep; 105(37):1174-9. PubMed ID: 814616
[TBL] [Abstract][Full Text] [Related]
11. [Immunoglobulin composition of the blood in hemolymphoblastosis].
Medina F; Tognella S
Folia Allergol (Roma); 1967; 14(6):447-52. PubMed ID: 4171226
[No Abstract] [Full Text] [Related]
12. [The primary proliferative processes of the hemopoietic system].
Introzzi P
Minerva Med; 1969 Sep; 60(74):3399-450. PubMed ID: 4981171
[No Abstract] [Full Text] [Related]
13. Effects of cancer on the immune globulins and immunity.
Fahey JL
Proc Natl Cancer Conf; 1964; 5():417-20. PubMed ID: 4159237
[No Abstract] [Full Text] [Related]
14. [The antibody deficiency syndrome].
Ricci G
G Mal Infett Parassit; 1966 Dec; 18(12):Suppl:979-88. PubMed ID: 4173181
[No Abstract] [Full Text] [Related]
15. [Immunological anomalies observed during hyperlymphocytic chronic lymphoid leukemia].
Homberg JC; Cartron J; Ropars C; Cavaroc M; Salmon C
Nouv Rev Fr Hematol; 1971; 11(3):476-83. PubMed ID: 4108309
[No Abstract] [Full Text] [Related]
16. Immune deficiency states associated with malignant disease in man.
Harris J; Bagai RC
Med Clin North Am; 1972 Mar; 56(2):501-14. PubMed ID: 4623010
[No Abstract] [Full Text] [Related]
17. Presence of chronic lymphoid leukaemia associated antigen in other malignant haematological diseases.
Phan DT; Petrányi GG; Hollán SR
Vox Sang; 1974 Feb; 26(2):141-6. PubMed ID: 4207851
[No Abstract] [Full Text] [Related]
18. [Lymphomas and immunity].
Kouvalainen K
Duodecim; 1970; 86(16):886-94. PubMed ID: 4917099
[No Abstract] [Full Text] [Related]
19. [On the cell surface markers of lymphocytes in lymphoproliferative disorders (author's transl)].
Tanaka E
Rinsho Ketsueki; 1976 Jun; 17(6):600-17. PubMed ID: 823349
[No Abstract] [Full Text] [Related]
20. [Lympho-reticuloproliferative diseases--problems of differential diagnosis].
Stavem P
Tidsskr Nor Laegeforen; 1974 Nov; 94(32):2248-50. PubMed ID: 4216118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
